Genpact Limited (G) Options

This isn't aging well, is it?

It's not retail selling at bottom. There's an insider from the old deal that has "free" shares. That's why all of the selling has been routed through CDEL. Once it is done this will move up. Maybe 3x. Maybe 20x. But it will DEFINITELY move up. Could go lower until the seller is done too. 

if your looking for evidence on markers check out bbrw saying there is 100k outstanding and i have over 13 million in my portfolios

Exactly one month ago today, during Rory's comments about the 2024 10-K

To avoid this awful outcome, we developed a unique strategy to utilize Reg A to structure our capitalize raise initiatives and avoid the predatory hedge-fund investors, allowing us to issue straight common shares,

16th Coefficient will be revealed within the next 26 days!
https://investorshub.advfn.com/uimage/uploads/2025/3/28/pbhyu16TH_COEFFICIENT_EXPANDED_VALUES.png
1st Quarter 2019 $53,369
2nd Quarter 2019 $0
3rd Quarter 2019 $0
4th Quar

Just keep loading it .0001

Nice paint job at the close🤣 

hitman70 ...I will be glad when I sell at $2.00

Custodian taking his time with this one. Just keep loading it.

"Few shares"..???..LMMFAOOO...LO. 😎😎😎😎😎

Everybody here is gambling. Why some of you need to be so nasty is a mystery to me.

BEST SELLERS RANK (BSR) IS 351 18 Estimated Sold on Amazon Since APR 1 - 2ND Quarter 2025
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec

Not a lie...a poor spontaneous prediction maybe...but not a lie.
Out of the trips today? Wow, the lies just keep stacking up. You get your meds mixed up today old man? wtf

Grok
Thank you for providing the press release confirming Joseph Mills’ appointment as Chief Executive Officer and Director of International Battery Metals Ltd. (IBAT), effective April 7, 2025. The release also details his compensation, including 3,000,000 restricted share units (RSUs) tied t

AUTL just presented preliminary data from an initial six patient cohort treated in a PhI trial in systemic lupus erythematosus, which supports them progressing obe-cel into a planned PhII pivotal trial (N=30) in severe refractory lupus nephritis. The first patient is expected to be dosed by the end

In a field with no approved treatments and devastating impacts on young lives, Thiogenesis Therapeutics (TTI.v TTIPF) is advancing TTI-0102—an innovative therapy designed to restore mitochondrial health and target the root causes of MELAS.

With cytoprotective, antioxidant, and mitocho

Recent filings show No Reverse Split

29 mil shares outstanding

Market Cap is very low

Should go to .50 cents in a month

Ec

Well, I am thinking that the financials have been misplaced. It could happen to anyone.

I didn't want to talk about the patent details because I was lazy, but I'm telling you because you keep mentioning it.
Well, you don't know anything about patents, but you should ask patent attorney friend.
According to the scope of the MDASE initial application patent right (claim par

Yves also knows by now that LWLG doesn't have a working product and is doomed to the pink sheets. Collecting pay checks seems to be his mission for now.

Vaporware

So the scam changed names and will soon be out of carbon cig filters right? They didn't overcome zilch. They reversed into their own sham. You speak for no one ever.

is requiring another confirmatory trial

Seems to me, with all the data and the safety profile of DCVax-L doing a confirmatory is a death sentence to those it may benefit.

Why not do something similar to a P4 trial? Conditional approval with future data requirements.

Richie if he invites investors to a party in Spain how many would go?

I better get my passport in gear.
I would want to take one of my Spanish speaking friends too so i know everything that is said in Spanish, not just in English

Premium Resources (PREM.v PRMLF) has completed its ~34,300m infill drill program at Selebi North in Botswana, reporting standout intercepts like 27.55m at 4.97% CuEq. With results exceeding its 2024 MRE, the company now shifts focus to expansion drilling in high-potential EM target zones. Full DD⬇️